Quick Takeaways
- Paul Bisaro has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,975,149.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Paul Bisaro
- Location
- Parsippany, NJ
- Summary
- The estimated net worth of Paul Bisaro is at least $3,975,149 dollars as of 25 Feb 2026. Paul Bisaro is the Director of Zoetis Inc. and owns shares of Zoetis Inc. (ZTS) stock worth about $3.22M. Paul Bisaro is the Director of Keenova Therapeutics plc and owns shares of Keenova Therapeutics plc stock worth about $370.8K. Paul Bisaro is the Director of MYRIAD GENETICS INC and owns shares of MYRIAD GENETICS INC (MYGN) stock worth about $362.5K. Paul Bisaro is the Director of TherapeuticsMD, Inc. and owns shares of TherapeuticsMD, Inc. (TXMD) stock worth about $18.2K.
- Signature
- /s/ Mark Tyndall, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Paul Bisaro and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Zoetis Inc. ($3,223,698).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Paul Bisaro
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ZTS | Zoetis Inc. | Director | $3,223,698 | 19 Feb 2026 | ||
| Keenova Therapeutics plc | Director | $370,798 | 23 Feb 2026 | |||
| MYGN | MYRIAD GENETICS INC | Director | $362,462 | 05 Jun 2025 | ||
| TXMD | TherapeuticsMD, Inc. | Director | $18,191 | 29 Sep 2022 |
Insider Transactions Reported by Paul Bisaro:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.